3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Stress Disorders, Post-Traumatic
2
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obsessive-Compulsive Disorder
1
Neoplasms
1
Melanoma, Cutaneous Malignant
1
Anxiety Disorders
1
Interventions
pembrolizumab
3
Paclitaxel
2
relatlimab
1
nintedanib
1
lifileucel
1
dabrafenib
1
Vitamin D
1
Temozolomide
1
Surveys and Questionnaires
1
Opdualag
1
Nivolumab
1
Ipilimumab
1
Eye Movement Desensitization Reprocessing
1
Electrochemotherapy
1
Dacarbazine
1
Cholecalciferol
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Melanoma, Cutaneous Malignant
×
Eye Movement Desensitization Reprocessing
×
Clear all
NCT06767332
2025-01-09
FAME
Leiden University Medical Center
Phase NA
Recruiting
30 enrolled